Morgan Stanley rates HLS as Equal-weight – Marketscreener.com

While price earnings (PE) multiples have generally contracted for the Australian Healthcare sector, they remain above the
levels when the Australian 10 year bond yield was last around 4% in 2013, notes Morgan Stanley.

As a result, the broker favours those stocks where the growth outlook is now better than in 2013 or EPS certainty is high.

The Equal-weight rating and $3.75 target are retained for Healius. Industry view In-Line.

Sector: Health Care Equipment & Services.

Target price is $3.75.Current Price is $3.76. Difference: ($0.01) – (brackets indicate current price is over target). If HLS meets the Morgan Stanley target it will return approximately 0% (excluding dividends, fees and charges – negative figures indicate an expected loss).

© 2022 Acquisdata Pty Ltd., source FN Arena